All In Biotech

Free tool

FAERS Monitor: Ofev

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205832 or its brand name (Ofev, Nintedanib Esylate). Reports on generic versions are filed under their own applications.

Reports

32,515

Serious

22,042

68% of reports

Hospitalization

10,897

Death reported

6,449

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea10,539
  • nausea4,818
  • dyspnoea4,179
  • cough3,397
  • death3,386
  • decreased appetite3,188
  • weight decreased3,173
  • fatigue3,033
  • vomiting2,828
  • idiopathic pulmonary fibrosis2,209
  • headache2,071
  • constipation2,053
  • abdominal pain upper1,925
  • asthenia1,760
  • abdominal discomfort1,683

Reports by year received

View as table
YearReports
20121
20133
201436
2015960
20161,298
20171,463
20181,924
20192,057
20202,461
20213,012
20223,745
20233,790
20244,276
20253,898
20263,591

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,644 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
idiopathic pulmonary fibrosisSignal2,209816.6767.6794,911
diarrhoeaSignal10,53910.710.694,250
decreased appetiteSignal3,1889.08.722,564
coughSignal3,3977.97.720,556
weight decreasedSignal3,1737.47.217,670
abdominal discomfortSignal1,6836.56.27,885
constipationSignal2,0536.15.98,833
abdominal pain upperSignal1,9256.15.88,198
dyspnoeaSignal4,1794.84.712,834
nauseaSignal4,8184.03.910,987
vomitingSignal2,8283.93.86,220
astheniaSignal1,7603.02.92,435
deathSignal3,3862.52.53,307
fatigueSignal3,0332.52.42,890
headacheSignal2,0712.12.11,292

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.